Clinical trials should include older adults, ASCO urges

The American Society of Clinical Oncology (ASCO) has called on federal agencies and the cancer research community to broaden clinical trials to include older adults. They also called for work to be done to redefine the eligibility for clinical trials. Both calls to action were published in the Journal of Clinical Oncology. In the US, more than 60% of cancers occur in people age 65 and older. Due to an ageing population, this will likely increase over the coming years, yet the evidence base for treating older adults is sparse as they are underrepresented in clinical trials and trials designed